Andrew P. Smith
2016
In 2016, Andrew P. Smith earned a total compensation of $1.1M as Former Chief Financial Officer at Sucampo Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,961 |
|---|---|
| Option Awards | $415,502 |
| Salary | $364,518 |
| Other | $95,894 |
| Total | $1,059,874 |
Smith received $415.5K in option awards, accounting for 39% of the total pay in 2016.
Smith also received $184K in non-equity incentive plan, $364.5K in salary and $95.9K in other compensation.
Rankings
In 2016, Andrew P. Smith's compensation ranked 7,963rd out of 14,075 executives tracked by ExecPay. In other words, Smith earned more than 43.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,963 out of 14,075 | 43rd |
Division Manufacturing | 3,035 out of 5,486 | 45th |
Major group Chemicals And Allied Products | 1,008 out of 1,900 | 47th |
Industry group Drugs | 780 out of 1,543 | 49th |
Industry Pharmaceutical Preparations | 617 out of 1,173 | 47th |
Source: SEC filing on April 21, 2017.
Smith's colleagues
We found four more compensation records of executives who worked with Andrew P. Smith at Sucampo Pharmaceuticals in 2016.
2016
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2016
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2016
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
2016
Matthias Alder
Sucampo Pharmaceuticals